scholarly article | Q13442814 |
P356 | DOI | 10.1002/JMRI.22598 |
P698 | PubMed publication ID | 21698707 |
P50 | author | Jonathan Melamed | Q38546667 |
Lorenzo Mannelli | Q46986804 | ||
Samir S Taneja | Q56516562 | ||
Andrew B Rosenkrantz | Q83935812 | ||
P2093 | author name string | James S Babb | |
Douglas S Berkman | |||
Xiangtian Kong | |||
Ben E Niver | |||
P2860 | cites work | Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer | Q33545512 |
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation | Q33746637 | ||
Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection | Q34017719 | ||
Imaging localized prostate cancer: current approaches and new developments. | Q36469177 | ||
Functional MR imaging of prostate cancer | Q36712065 | ||
Imaging prostate cancer: a multidisciplinary perspective | Q36773229 | ||
Will focal therapy become a standard of care for men with localized prostate cancer? | Q36983662 | ||
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. | Q37073257 | ||
Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study | Q37328891 | ||
Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience. | Q37401547 | ||
Characterization of genitourinary lesions with diffusion-weighted imaging | Q37597781 | ||
Is focal therapy the future for prostate cancer? | Q37690305 | ||
Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging | Q46587227 | ||
Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. | Q46644825 | ||
Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion. | Q51684727 | ||
Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region | Q51867614 | ||
Body diffusion-weighted MR imaging using high b-value for malignant tumor screening: usefulness and necessity of referring to T2-weighted images and creating fusion images | Q53022397 | ||
High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. | Q53485817 | ||
Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results | Q53557589 | ||
Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers | Q56783298 | ||
Prostate Cancer: Comparison of Tumor Visibility on Trace Diffusion-Weighted Images and the Apparent Diffusion Coefficient Map | Q57385827 | ||
P433 | issue | 1 | |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 95-100 | |
P577 | publication date | 2011-07-01 | |
P1433 | published in | Journal of Magnetic Resonance Imaging | Q15761156 |
P1476 | title | Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization | |
P478 | volume | 34 |
Q57132074 | A Brief Review of the Combined Use of T2-Weighted MRI and Diffusion-Weighted Imaging for Prostate Cancer Diagnosis |
Q102220527 | A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk |
Q47681129 | Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2. |
Q37600905 | Comparison of T2(*) mapping with diffusion-weighted imaging in the characterization of low-grade vs intermediate-grade and high-grade prostate cancer |
Q36376149 | Consistency of T2WI-FS/ASL fusion images in delineating the volume of nasopharyngeal carcinoma |
Q47955825 | Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI |
Q43525988 | Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T |
Q35663658 | Diffusion-weighted MR imaging in gynecologic cancers |
Q34742733 | Diffusion‐weighted MRI and its role in prostate cancer |
Q57133021 | Imaging Prostate Cancer |
Q33891781 | Imaging and intervention in prostate cancer: Current perspectives and future trends |
Q95261500 | Is dynamic contrast enhancement still necessary in multiparametric magnetic resonance for diagnosis of prostate cancer: a systematic review and meta-analysis |
Q45258501 | Meta-analysis of Diffusion-Weighted Magnetic Resonance Imaging in Detecting Prostate Cancer |
Q48526495 | Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging |
Q52981879 | Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone. |
Q29037908 | PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 |
Q50138480 | Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted Biopsy |
Q37447030 | Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI. |
Q30436923 | Prostate specific antigen: the past, present and future |
Q37032783 | Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate |
Q47410159 | The diagnostic accuracy of high b-value diffusion- and T2-weighted imaging for the detection of prostate cancer: a meta-analysis |
Q38215292 | The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis |
Q42697744 | Use of Magnetic Resonance Imaging to Accurately Detect and Stage Prostate Cancer: The Hype and the Hope |
Q38670271 | Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2. |
Q30662431 | Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques |
Q88758730 | [Value of PI-RADS v2 scores combined with prostate specific antigen in diagnosis of peripheral zone prostate cancer: a logistic regression analysis] |
Search more.